Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Passage BIO, Inc. (PASG)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-KS-1
Net income  -136.1-185.4-112.2-45.6-12.8
Depreciation and amortization  3.71.50.80.1 
Stock-based compensation  19.032.714.61.5 
Change in working capital   [+]-10.010.118.9-7.20.0
Other operating activities  5.314.2-2.611.3-5.8
Cash from operations  -118.2-126.9-80.5-39.9-18.6
   
Capital expenditures  -2.3-17.6-1.1-1.20.0
Purchases of intangible assets  -3.0-8.0-0.5-0.5-2.5
Purchases of short-term investments, net  30.5-20.2-170.5  
Cash from investing  25.2-45.8-172.1-1.7-2.5
   
Issuance of common stock, net   165.8228.3  
Option exercises  0.41.20.30.2 
Financing costs     -0.8 
Other cash from financing  -0.92.00.8175.046.0
Cash from financing  -1.4166.7228.8175.646.0
   
Free cash flow  -120.5-144.5-81.7-41.1-18.6
        Per share (diluted)  ($2.21)($2.71)($2.11)($9.70)($5.17)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy